Literature DB >> 19262964

Methodological issues in the non pharmacological treatment of BPSD in nursing home--the TNM study.

E Leone1, A Deudon, N Maubourguet, X Gervais, P H Robert.   

Abstract

Behavioural and psychological symptoms of dementia (BPSD) such as agitation, aggressiveness, oppositional behaviour and psychotic symptoms are often reported by caregivers and staff members in institutions for the elderly. Taking into account the limited efficacy and the importance of side effects observed with psychotropic agents, the majority of existing guideline underlines the importance of non-pharmacological strategies. The aim of this article is to describe the major methodological problems in non-pharmacological treatments studies and to present the design of the TNM study, a nursing home randomized controlled trial conducted in 16 French nursing homes.

Entities:  

Mesh:

Year:  2009        PMID: 19262964     DOI: 10.1007/s12603-009-0069-y

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  12 in total

Review 1.  Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

Authors:  Gill Livingston; Kate Johnston; Cornelius Katona; Joni Paton; Constantine G Lyketsos
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

2.  Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.

Authors:  M Benoit; C Arbus; F Blanchard; V Camus; V Cerase; J P Clement; P Fremont; O Guerin; C Hazif Thomas; F Jeanblanc; C Lafont; O Moreaud; M Pedra; M Poncet; S Richard Harston; A S Rigaud; M E Sotto Martin; J Touchon; B Vellas; L J Fitten; P H Robert
Journal:  J Nutr Health Aging       Date:  2006 Sep-Oct       Impact factor: 4.075

Review 3.  Defining empirically supported therapies.

Authors:  D L Chambless; S D Hollon
Journal:  J Consult Clin Psychol       Date:  1998-02

Review 4.  Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review.

Authors:  Liat Ayalon; Amber M Gum; Leilani Feliciano; Patricia A Areán
Journal:  Arch Intern Med       Date:  2006-11-13

5.  Functional status and cognitive impairment in Alzheimer's patients with and without depression.

Authors:  J L Pearson; L Teri; B V Reifler; M A Raskind
Journal:  J Am Geriatr Soc       Date:  1989-12       Impact factor: 5.562

6.  Assessing quality of life in older adults with cognitive impairment.

Authors:  Rebecca G Logsdon; Laura E Gibbons; Susan M McCurry; Linda Teri
Journal:  Psychosom Med       Date:  2002 May-Jun       Impact factor: 4.312

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  An observational study of agitation in agitated nursing home residents.

Authors:  J Cohen-Mansfield; P Werner; M S Marx
Journal:  Int Psychogeriatr       Date:  1989       Impact factor: 3.878

9.  The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study.

Authors:  B C Jost; G T Grossberg
Journal:  J Am Geriatr Soc       Date:  1996-09       Impact factor: 5.562

Review 10.  Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia.

Authors:  L Clare; R T Woods; E D Moniz Cook; M Orrell; A Spector
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  3 in total

1.  Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease.

Authors:  S Gauthier
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

2.  Editorial: can we improve care for patients with dementia?

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  The Hyperactivity-Impulsivity-Irritiability-Disinhibition-Aggression-Agitation Domain in Alzheimer's Disease: Current Management and Future Directions.

Authors:  Rachel M Keszycki; Daniel W Fisher; Hongxin Dong
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.